Remus Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | ||
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 1.09 | 1.00 | 0.01 | 0.01 | |
| Share application money | - | - | - | - | |
| Preference share capital | - | - | - | - | |
| Reserves & surplus | 18.05 | 5.43 | 3.04 | 2.01 | |
| Loan funds | |||||
| Secured loans | 7.94 | 0.19 | 0.28 | 0.36 | |
| Unsecured loans | - | - | - | - | |
| Total | 27.08 | 6.62 | 3.33 | 2.38 | |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 3.49 | 0.79 | 0.72 | 0.65 | |
| Less : revaluation reserve | - | - | - | - | |
| Less : accumulated depreciation | 0.94 | 0.48 | 0.33 | 0.15 | |
| Net block | 2.54 | 0.31 | 0.39 | 0.50 | |
| Capital work-in-progress | 0.02 | - | - | - | |
| Investments | 20.62 | 3.07 | 0.07 | - | |
| Net current assets | |||||
| Current assets, loans & advances | 11.48 | 12.53 | 10.59 | 4.80 | |
| Less : current liabilities & provisions | 7.58 | 9.29 | 7.72 | 2.92 | |
| Total net current assets | 3.90 | 3.25 | 2.87 | 1.88 | |
| Miscellaneous expenses not written | - | - | - | - | |
| Total | 27.08 | 6.62 | 3.33 | 2.38 | |
| Notes: | |||||
| Book value of unquoted investments | 20.62 | 3.07 | - | - | |
| Market value of quoted investments | - | - | - | - | |
| Contingent liabilities | 94.36 | - | - | - | |
| Number of equity sharesoutstanding (Lacs) | 10.85 | 10.00 | 0.10 | 0.10 | |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis